Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Chaerin Woo, Won-Il Jeong

Clin Mol Hepatol. 2024;30(2):299-302. Published online February 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0113

View: 1268 Download: 57

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong

Clin Mol Hepatol. 2020;26(4):697-704. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0152

View: 6013 Download: 143 Web of Science: 9 Crossref: 7

Dong Joon Kim, Won-Il Jeong, Hidekazu Tsukamoto, Bin Gao

Clin Mol Hepatol. 2020;26(4):584-585. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0271

View: 3455 Download: 72

Viewed By 5681	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4936	MAFLD: How is it different from NAFLD?
Viewed By 4706	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3819	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3802	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Author :

Author index